TSC-204-A0101

N/A

Report date: 2024/04/28 20:00:08

Base Information

Drug NameTSC-204-A0101
Drug Alias NameTSC-204-A0101
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionMelanoma-associated antigen 1 modulators
TargetsMelanoma-associated antigen 1
Therapy Area/IndicationsPenile NeoplasmsVulvar NeoplasmsUterine Cervical Neoplasms +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTScan Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTScan Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPenile NeoplasmsVulvar NeoplasmsUterine Cervical Neoplasms +[15] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A